Clinical Trials Directory

Trials / Terminated

TerminatedNCT00636324

Level of Continuous Positive Airway Pressure (CPAP) in Preterm Infants After Extubation (L-CPAP Study)

Nasal Continuous Positive Airway Pressure in Preterm Infants After Extubation: Comparison of Different Levels of Pressure

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
23 (actual)
Sponsor
Hamilton Health Sciences Corporation · Academic / Other
Sex
All
Age
14 Days
Healthy volunteers
Not accepted

Summary

Despite widely used of nasal CPAP in preterm infants, uncertainties regarding aspects of its application remain. Clinical indications vary greatly between institutions, especially when combined with varieties of systems, devices, and techniques available. One of the controversial aspects that needs to be clarified is the level of pressure which should be used. The objective of the study is to compare the effectiveness of two ranges of nCPAP pressure that are within the spectrum of current practice for post-extubation support in very preterm infants.

Detailed description

The use of nCPAP has been established as an effective respiratory support to prevent extubation failure and as treatment of other pulmonary diseases. An upsurge in its popularity has resulted in some controversial aspects, including the level of pressure to be used. The level that has been used in very preterm infants after extubation, which mostly came from anecdotal data, varies from 3 to 10 cmH2O. Physiologic studies show higher nCPAP pressures improve lung mechanical properties. Though potential side effects have been of concern in practical application, there is no formal evidence supporting the concept that increased CPAP pressure results in a higher risk of complications. In relatively stable preterm infants, the range of optimal CPAP level needs to be established in order to adequately support the upper airway and lungs, without increasing complications secondary to the pressure applied. Given the uncertainty of the nCPAP pressure that should be used in very preterm infants, we conduct a randomized controlled trial to compare the effectiveness of two ranges of nCPAP pressure for post-extubation support in very preterm infants. The purpose of this trial is to compare the rate of successful extubation of using the nasal CPAP level of 7 to 9 cmH2O compared to level of 4 to 6 cmH2O.

Conditions

Interventions

TypeNameDescription
DEVICENasal CPAP, level 7 to 9 cmH2OApply nasal CPAP pressure of 7-9 H2O for the first 72 hours of extubation
DEVICENasal CPAP, level 4 to 6 cmH2OApply nasal CPAP pressure of 4 to 6 cmH2O for the first 72 hours of extubation

Timeline

Start date
2007-07-01
Primary completion
2008-03-01
Completion
2010-06-01
First posted
2008-03-14
Last updated
2009-02-10

Source: ClinicalTrials.gov record NCT00636324. Inclusion in this directory is not an endorsement.